Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)
China · Delayed Price · Currency is CNY 80.00
-1.68 (-2.06%)
Oct 16, 2026, 3:04 PM CST
SHE:300436 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
| 13,442 | 14,199 | 5,203 | 4,082 | 6,237 | 7,626 | |
Market Cap Growth | -29.67% | 172.88% | 27.47% | -34.55% | -18.22% | 40.97% |
Enterprise Value | 13,818 | 14,474 | 5,570 | 4,394 | 6,256 | 7,352 |
Last Close Price | 80.00 | 89.15 | 32.67 | 25.63 | 39.16 | 48.03 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Forward PE | - | 46.43 | 46.43 | 46.43 | 46.43 | 46.43 |
PS Ratio | 31.43 | 34.10 | 11.79 | 9.66 | 16.17 | 20.59 |
PB Ratio | 49.32 | 41.00 | 13.11 | 7.17 | 6.53 | 7.26 |
P/TBV Ratio | 91916.90 | 254.49 | 105.00 | 24.67 | 8.11 | 8.81 |
P/OCF Ratio | - | - | 251.27 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 32.31 | 34.76 | 12.62 | 10.39 | 16.22 | 19.85 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 1.75 | 1.32 | 1.12 | 0.81 | 0.33 | 0.18 |
Net Debt / Equity Ratio | 1.15 | 0.70 | 0.75 | 0.45 | 0.08 | -0.20 |
Net Debt / EBITDA Ratio | -5.16 | -6.04 | -9.99 | -1.83 | -0.43 | 7.04 |
Net Debt / FCF Ratio | -2.72 | -2.56 | -6.45 | -0.68 | -0.23 | 1.07 |
Asset Turnover | 0.32 | 0.29 | 0.29 | 0.27 | 0.26 | 0.30 |
Inventory Turnover | 1.53 | 1.60 | 1.79 | 2.07 | 2.16 | 2.09 |
Quick Ratio | 0.52 | 0.70 | 0.42 | 0.50 | 0.72 | 1.50 |
Current Ratio | 0.86 | 1.08 | 0.71 | 0.75 | 0.97 | 1.82 |
Return on Equity (ROE) | -82.74% | -65.09% | -35.71% | -49.17% | -14.02% | -4.19% |
Return on Assets (ROA) | -6.63% | -5.81% | -5.11% | -8.53% | -9.56% | -4.13% |
Return on Invested Capital (ROIC) | -24.30% | -20.57% | -16.40% | -22.88% | -24.04% | -10.80% |
Return on Capital Employed (ROCE) | -17.90% | -14.20% | -14.40% | -20.90% | -20.70% | -7.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Earnings Yield | -1.63% | -1.53% | -3.00% | -8.54% | -2.04% | -0.46% |
FCF Yield | -0.86% | -0.67% | -0.89% | -9.21% | -5.06% | -2.52% |
Buyback Yield / Dilution | 0.01% | -0.00% | 0.00% | -0.06% | -6.54% | -6.43% |
Total Shareholder Return | 0.01% | -0.00% | 0.00% | -0.06% | -6.54% | -6.43% |